期刊文献+

IL-2与IL-10浓度变化对Graves病治疗效果的预测 被引量:7

Detecting IL-2 and IL-10 to predicate treatment outcome for Graves disease
暂未订购
导出
摘要 目的:探讨IL-2和IL-10变化对Graves病(Graves disease,GD)治疗转归的影响。方法:以2007年1月至2008年12月入我院治疗的GD患者72例,分别于治疗前及治疗后5月检测IL-2和IL-10及甲状腺素水平,评价IL-2和IL-10水平与治疗转归的关系。结果:72例GD患者甲亢未控制者21例,甲亢控制者35例,早发性甲减者16例。IL-2在甲亢未控制者水平最高,甲亢控制者次之,而早发性甲减者最低(P<0.05);IL-10水平则成反变趋势(P<0.05)。治疗后甲亢未控制者治疗后IL-2升高,甲亢控制者IL-2基本不变,而早发性甲减者IL-2下降(P<0.05);IL-10水平也成反变趋势(P<0.05)。IL-2/IL-10水平在甲亢控制者水平最高,甲亢控制者次之,而早发性甲减者最低(P<0.05);而治疗前后IL-2/IL-10水平基本相当(P>0.05)。结论:IL-2/IL-10比值越高甲亢越难控制,比值越低越易产生甲减;IL-2/IL-10是较好的GD治疗效果预测指标。 Objective:To investigate the IL-2 and IL-10 changes impact of treatment outcome in Graves disease(GD).Methods:From January 2007 to December 2008,72 cases of patients with GD in our hospital were detected IL-2 and IL-10 and thyroid hormone levels before and after treatment respectively,the relationship between the IL-2 and IL-10 level with prognosis was evaluated.Results:There are 21 cases of GD in patients with uncontrolled hyperthyroidism,35 cases with hyperthyroidism control,16 cases of early-onset hypothyroidism.The level of IL-2 in uncontrolled hyperthyroidism were the highest,followed by hyperthyroidism control,and in early-onset hypothyroidism were the lowest(P 0.05);IL-10 levels into the trend of anti-change(P0.05).After treatment,IL-2 increased in uncontrolled hyperthyroidism,in hyperthyroidism control,IL-2 was essentially the same,and in early-onset hypothyroidism,IL-2 decreased(P 0.05);IL-10 levels into the anti-change(P 0.05).IL-2/IL-10 was highest level in uncontrolled hyperthyroidism,followed by hyperthyroidism control,and in early-onset hypothyroidism was the lowest(P0.05);and the level of IL-2/IL-10 was the same before and after treatment(P0.05).Conclusion:The higher IL-2/IL-10 ratio shows more difficult for control hyperthyroidism,the lower IL-2/IL-10 ratio shows more easy to produce hypothyroidism;IL-2/IL-10 is a good predictor for GD treatment outcome.
作者 李春北
出处 《重庆医科大学学报》 CAS CSCD 北大核心 2010年第3期412-414,共3页 Journal of Chongqing Medical University
关键词 GRAVES病 细胞因子 IL-2 IL-10 疗效 Graves disease Cytokines IL-2 IL-10 Treatment outcome
  • 相关文献

参考文献5

  • 1Gianoukakis A G,Khadavi N,Smith T J.Cytokines,Graves' disease,and thyroid-associated ophthalmopathy[J].Thyroid,2008,18(9):953-958.
  • 2Molnar I.The balance shift in Th1/Th2 related IL-12/IL-5 cytokines in Graves' disease during methimazole therapy[J].Autoimmunity,2007,40(1):31-37.
  • 3Kocjan T,Wraber B,Repnik U,et al.Changes in Th1/Th2 cytokine balance in Graves' disease[J].Pflugers Arch,2000,440 (5):94-95.
  • 4李睿,杨锡强.IL-10与树突状细胞的免疫调控作用[J].国外医学(免疫学分册),2004,27(3):129-132. 被引量:9
  • 5Fukao A,Takamatsu J,MurakamiY,et al.The relationship of psychological factors to the prognosis of hyperthyroidism in antithyroid drug-treated patients with Graves' disease[J].Clinical Endocrinology,2003,58(5):550-555.

二级参考文献20

  • 1Kubsch S,Graulich E,Knop J,et al.Suppressor activity of anergic T cells induced by IL-10-treated human dendritic cells:association with IL-2- and CTLA-4-dependent G1 arrest of the cell cycle regulated by p27Kip1.[J].Eur J Immunol,2003,33(7):1988-1997.
  • 2Chang CC,Wright A ,Punnonen J.Monocyte-derived CD1a+ and CD1a- dendritic cell subsets differ in their cytokine production profiles,susceptibilities to transfection,and capacities to direct Th cell differentiation.[J].J Immunol,2000 ,165(7):3584-3591.
  • 3Xia CQ,Kao KJ.Suppression of interleukin-12 production through endogenously secreted interleukin-10 in activated dendritic cells:involvement of activation of extracellular signal-regulated protein kinase.[J].Scand J Immunol,2003,58(1):23-32.
  • 4Hickman SP,Chan J ,Salgame P.Mycobacterium tuberculosis induces differential cytokine production from dendritic cells and macrophages with divergent effects on naive T cell polarization.[J].J Immunol ,2002,168(9):4636-4642.
  • 5McGuirk P ,McCann C,Mills KH.Pathogen-specific T regulatory 1 cells induced in the respiratory tract by a bacterial molecule that stimulates interleukin 10 production by dendritic cells:a novel strategy for evasion of protective T helper type 1 responses
  • 6Maldonado-lopez R,Maliszewski C,Urbain J,et al.Cytokines regulate the capacity of CD8alpha(+) and CD8alpha(-) dendritic cells to prime Th1/Th2 cells in vivo.[J].J Immunol ,2001,167(8):4345-4350.
  • 7Moore KW,de Waal Malefyt R W,Coffman RL,et al.Interleukin-10 and the interleukin-10 receptor.[J].Annu Rev lmmnol,2001,19:683-765.
  • 8Corinti S,Albanesi C,la Sala A,et al.Regulatory activity of autocrine IL-10 on dendritic cell functions.[J].J Immunol,2001,166(7) :4312-4318.
  • 9Steinbrink K,Granlich E,Kubsch S,et al.CD4(+) and CD8(+) anergic T cells induced by interleukin-10-treated human dendritic cells display antigen-specific suppressor activity.[J].Blood,2002,99(7):2468-2476.
  • 10Akbari O,Dekruyff RH ,Umetsu DT.Pulmonary dendritic cells producing IL-10 mediate tolerance induced by respiratory exposure to antigen.[J].Nat Immunol ,2001,2(8):725-731.

共引文献8

同被引文献77

二级引证文献181

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部